| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0073 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |